Together with limitations due to toxicity and adverse drug interactions, this might explain why none of the studies aimed at overcoming drug resistance by ABC members translated into successful clinical application. F I G U R E 1 ATP-binding cassette subfamily C member 1 (ABCC1) A, expression is upregulated and B, peptide phosphorylation is increased in gemcitabine-resistant PANC1 cells (ATCC). Biological replicates were prepared from cell lysates of PANC1 and its resistant counterpart. Insolution digestion was performed, and samples were enriched for phosphopeptides with titanium dioxide beads, or directly measured on mass spectrometry. Raw data are deposited under PXD010112. 4 The authors observed that cell growth in spheroids induced chemoresistance, regardless of prior ABCG2 expression. ABCG2 was upregulated in this cell culture system, leading to the conclusion that ABCG2 expression correlates to stemness in this model. The effect of model selection, however, needs to be taken into account for interpretation of results. For instance, Longati et al noted metabolism and gene expression shifts in tumor spheroids, inducing chemoresistance. 8 Also, gemcitabine-resistant populations have been shown to harbor CSC potential after in vivo selection, 9 emphasizing that the plasticity of cell phenotypes depends on experimental model. Another chemoresistance factor that can be responsible for divergent results between culture conditions is mechanobiology. This novel field has been suggested to play a pivotal role in PDAC, 10 and will need to be further explored with regard to gene and ABC expression, in order to understand its role in sphere and in vivo chemoresistance.
10,11
Sasaki et al 1 tied the ABCG2 expression spheroids to observed drug resistance since verapamil treatment reversed chemoresistance. 1 Given that ABC transporters have other tumor-driving functions as well as transport, the effect of verapamil monotherapy should be considered as a control. As we have shown, inhibition of ABC transporters can affect viability by itself, overestimating the effect of drug transport inhibition. Moreover, verapamil was previously found to be inactive against ABCG2. 11 This inactivity might explain why verapamil was able to improve chemoresistance on spheroids of both origins, independent of ABCG2 expression, and why it most likely influenced other another oncogenic pathway in PDAC cells resulting in improved drug sensitivity. In-depth analysis with controlled gene modulation is needed to elucidate the true role of ABCG2 in PDAC progression and chemoresistance.
In conclusion, chemoresistance contributes to poor prognosis in PDAC patients, and understanding the mechanisms that underlie this 
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